CHTR vs SER · P/E 11, rev $55.09B vs rev $56.0K
Charter Communications Inc (CHTR) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. SER currently screens at market cap $29.7M.
Not investment advice. Open the CHTR and SER stock pages for the full models.
Not investment advice.